COVID 19 Profile: In early 2020, Aalto Bio launched the first recombinant SARS-COVID 19 Nucleocapsid Protein for diagnostic test manufacturers, vaccine developers and researchers globally. The Nucleocapsid protein plays a fundamental role during vaccine assembly through its interactions with the viral genome and membrane protein M, and it also plays a vital part in enhancing… Read more »
Menu
0
0
Weeks
0
0
Days
0
0
Hours
0
0
Minutes
0
0
Seconds
2023-03-27 09:002023-03-28 16:00Europe/LondonAttending BioMedicaBioMedicaVirtual
Organised by:
ACSLM
Email: kirstenhill@stepex.com
Website: https://acslm.ie/